Subependymomas of the fourth ventricle: To operate or not to operate?


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 14 08 2023
revised: 25 10 2023
accepted: 31 10 2023
medline: 27 11 2023
pubmed: 10 11 2023
entrez: 9 11 2023
Statut: ppublish

Résumé

There is a paucity of literature regarding the clinical characteristics and management of subependymomas of the fourth ventricle due to their rarity. Here, we describe the operative and non-operative management and outcomes of patients with such tumors. This retrospective single-institution case series was gathered after Institutional Review Board (IRB) approval. Patients diagnosed with a subependymoma of the fourth ventricle between 1993 and 2021 were identified. Clinical, radiology and pathology reports along with magnetic resonance imaging (MRI) images were reviewed. Patients identified (n = 20), showed a male predominance (n = 14). They underwent surgery (n = 9) with resection and histopathological confirmation of subependymoma or were followed with imaging surveillance (n = 11). The median age at diagnosis was 51.5 years. Median tumor volume for the operative cohort was 8.64 cm Surgical resection is safe and is associated with alleviation of presenting symptoms in patients with large tumors. Observation and routine surveillance are warranted for smaller, asymptomatic tumors.

Sections du résumé

BACKGROUND BACKGROUND
There is a paucity of literature regarding the clinical characteristics and management of subependymomas of the fourth ventricle due to their rarity. Here, we describe the operative and non-operative management and outcomes of patients with such tumors.
METHODS METHODS
This retrospective single-institution case series was gathered after Institutional Review Board (IRB) approval. Patients diagnosed with a subependymoma of the fourth ventricle between 1993 and 2021 were identified. Clinical, radiology and pathology reports along with magnetic resonance imaging (MRI) images were reviewed.
RESULTS RESULTS
Patients identified (n = 20), showed a male predominance (n = 14). They underwent surgery (n = 9) with resection and histopathological confirmation of subependymoma or were followed with imaging surveillance (n = 11). The median age at diagnosis was 51.5 years. Median tumor volume for the operative cohort was 8.64 cm
CONCLUSIONS CONCLUSIONS
Surgical resection is safe and is associated with alleviation of presenting symptoms in patients with large tumors. Observation and routine surveillance are warranted for smaller, asymptomatic tumors.

Identifiants

pubmed: 37944358
pii: S0967-5868(23)00330-2
doi: 10.1016/j.jocn.2023.10.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-152

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ali S Haider (AS)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Electronic address: aralam09@gmail.com.

Ian E McCutcheon (IE)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Chibawanye I Ene (CI)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Gregory N Fuller (GN)

Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Donald F Schomer (DF)

Neuroradiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Maria Gule-Monroe (M)

Neuroradiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Franco DeMonte (F)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Sherise D Ferguson (SD)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Frederick F Lang (FF)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Sujit S Prabhu (SS)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Shaan M Raza (SM)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Dima Suki (D)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Jeffrey S Weinberg (JS)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Raymond Sawaya (R)

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA; Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH